Amgen Inc. (AMGN) Amgen Meeting on Rare Disease (Transcript)

Amgen Inc. (NASDAQ:AMGN) Amgen Meeting on Rare Disease February 22, 2024 4:00 PM ET Company Participants Justin Claeys - Vice President of Investor Relations Murdo Gordon - EVP, Global Commercial Operations Vikram Karnani - Executive, Rare Disease Business Paul Burton - Chief Medical Officer James Bradner - Chief Scientific Officer Conference Call Participants Jay Olson - Oppenheimer Michael Yee - Jefferies Yaron Werber - TD Cowen Conor Mackay - Capital Markets Robyn Karnauskas - Truist Securities Chris Sc ...